Kalium Chloratum Biomedica (Potassium Chloride)

After oral ingestion, potassium chloride dissociates, releasing potassium ions that are absorbed into the bloodstream. These ions are taken up by cells via the Na+/K+‑ATPase pump, raising extracellular potassium concentrations and normalising the electrical gradients essential for nerve and muscle activity.

The exact dose of Kalium Chloratum Biomedica is determined by the prescribing clinician based on the patient’s serum potassium level, renal function, and overall clinical condition. Healthcare providers tailor the regimen to achieve safe and effective potassium repletion.

Safety data for Kalium Chloratum Biomedica in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and required import documentation.

Kalium Chloratum Biomedica provides potassium chloride, the most common and bioavailable potassium salt used for rapid correction of hypokalemia. Compared with potassium gluconate or citrate, chloride delivers a higher elemental potassium dose per gram, making it suitable for acute repletion, while other salts may be preferred for chronic supplementation due to gastrointestinal tolerability.

Store Kalium Chloratum Biomedica at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The product is taken orally, usually as a tablet, capsule, or liquid preparation, as directed by the prescriber. It should be swallowed with water and can be taken with or without food, unless specific instructions are provided.

The most serious risk is hyperkalemia, which can cause life‑threatening cardiac arrhythmias, especially in patients with renal impairment or those taking other potassium‑increasing drugs. Prompt monitoring of serum potassium and ECG is essential when high doses are used.

Patients with severe hyperkalemia, untreated Addison’s disease, or those on concurrent high‑dose potassium‑sparing therapies should avoid this product. Individuals with known hypersensitivity to potassium chloride or any excipients in the formulation should also not use it.